Cambridge-grade science
Methodology developed in the University of Cambridge genomics laboratory and refined with practising fertility consultants.
About BioBloom Life
Cambridge-grade microbiome science for reproductive care
BioBloom Life is a University of Cambridge spin-out building the diagnostic infrastructure for endometrial microbiome testing - so fertility and gynaecology teams can act on evidence, not assumption.
Spin-outFounded 2023 · UK & EU
Our mission
Every reproductive decision deserves Cambridge-grade science - delivered in a form clinicians and patients can act on
The BioBloom Life team
What we stand for
Three principles guiding everything we process
Methodology transparency
We publish the techniques behind every test and link the evidence - never a black box.
Patient-aware reporting
Reports are written so a clinician can act on them and a patient can understand them.
Our story
A Cambridge spin-out built around clinical reality
BioBloom Life began as a research programme into the endometrial microbiome and the role it plays in implantation, recurrent loss, and unexplained infertility. The company was founded to translate that work into a test fertility specialists can actually order.
We work hand-in-hand with consultants, embryologists, and gynaecologists across Europe - every methodology decision is shaped by clinical reality, not just bench science.
2023
Founded out of the University of Cambridge with a focus on the endometrial microbiome.
2024
Sequencing methodology refined and clinically validated.
2025
Methodology validated in partnership with UK fertility consultants and embryologists.
2026
Clinical pilot with NHS-affiliated and private fertility clinics across the UK.
Contact us
Let’s talk.
Whether you’re a clinician exploring microbiome-guided care, a clinic looking to partner with us, or a journalist - drop us a line and we’ll route it to the right person.
Office
BioBloom Ltd
Silverstream House, 45 Fitzroy Street
London, England, W1T 6EB